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Abstract
By 2020, the elderly (≥65-year-old) world population is projected to exceed one billion
individuals. This demographic megatrend has brought topics such as physiological age
and frailty to the forefront of medical research efforts around the globe. The concept of
frailty  has  evolved  significantly  since  the  mid-twentieth  century.  The  outdated
stereotype of a “thin, stooped, slow octogenarian” has transitioned to a more scientific
and  objective  understanding  of  the  problem.  Still,  a  comprehensive  and  concise
definition of “frailty” remains elusive. Until such a definition is firmly established and
universally  agreed  upon,  clinicians  continue  to  rely  on  the  somewhat  subjective
conceptual framework of today. In this chapter, the authors review key issues pertaining
to clinical management of frail patients, including diagnosis/identification, preventive
strategies,  therapeutic  approaches,  and common pitfalls.  The relationship between
frailty, various domains of life, and functional status is also discussed. Finally, we will
touch upon the concepts of end-of-life and goals of care, focusing on their relationship
to frailty.
Keywords: Frailty, Chronological age, Physiological age, Aging process, Objective as-
sessment
1. Introduction
The world population is projected to exceed 7.5 billion in 2020, with one billion to reach or
exceed 65 years of age [1, 2]. This demographic change has made frailty the focus of consid-
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erable scientific research, generating increasing interest during the past two decades [3–5]. As
more people make the transition across the life span [6], better understanding of the corre-
sponding changes and considerations is required. The concept of frailty has evolved substan-
tially  over the past  five decades.  The stereotypical  description of  a  “thin,  stooped,  slow
octogenarian” [7], although very vivid and generally reflective of a frail patient, has not been
matched with an equally concise definition. A comprehensive and objective definition of frailty
is needed in order to effectively diagnose, research, and improve the understanding of this
condition. Until such definition is universally agreed upon, clinicians will have to do their best
diagnosing frailty within the currently established framework. This chapter reviews some of
the key issues that practitioners may encounter when treating frail patients, including its
identification, preventive, and therapeutic options, as well as common pitfalls. We also discuss
the relationship between frailty and various domains of life and functional status, with a brief
overview of recent trends in the area of goals of care and end-of-life considerations.
2. What is frailty?
Frailty is a multifactorial phenomenon (Figure 1) that affects multiple domains of life
(Table 1). Our understanding of frailty has advanced significantly since the late 1960s, when
frail patients were described as “…confused, restless, incontinent… [and] …old” [8]. Twenty
years later, the frail population was described as “…elderly people with multiple prob-
lems…” [9]. Today’s definitions are more dynamic, elegant, and refined, with two main models
of frailty dominating the recent literature [10, 11]. The “phenotype model” of frailty, described
as “…a biologic syndrome of decreased reserve and impaired resistance to stressors, resulting
from cumulative declines across multiple physiological systems, and causing vulnerability to
Figure 1. Venn diagram showing the overlap of different domains, all of which contribute to the eventual development
and progression of frailty.
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adverse outcomes…” was proposed by Fried et al. [12]. This model requires the presence of
three out of the following five phenotypic criteria in order to define frailty: (a) low grip
strength; (b) low/decreased energy levels; (c) slow walking speed; (d) low physical activity;
and/or (e) unintentional weight loss [12]. The second model, developed by Rockwood et al.
takes into account “assets” and “deficits” which either aid or are detrimental to a patient’s
independent functioning [13, 14]. This model is closely tied to various indices currently used
as tools for assessing the degree of frailty in patients.
Impairment Activities affected Risks
Ambulatory dysfunction Driving Elder abuse/neglect
Cognitive decline Social interaction Financial theft
Impaired judgment General functional level Depression
Medication side effects Access to services/care Suicide
Impairment in eyesight Lack of understanding
Impairment in hearing
Education/prevention
Holistic assessment of the individual Realistic discussions about specific risks
Shared decision-making Advance directive
Established power-of-attorney Durable power of attorney
Do not wait for a crisis Review of medication profile
Screening for depression
Resources
Family and immediate social network Faith community
Adult day care communities Area association on aging
Alzheimer’s association Palliative care programs
Home health programs
Compiled with permission from Keller et al. (1999). J Am Geriatr Soc 47(11):1319–25; McGadney BF. (1995) African American
Research Perspectives 2(1):34; Panza et al. (2010). Am J Geriatr Psychiatry 18(2):98–116; Schulman-Green et al. (2006). Patient
Education & Counseling 63(1):145–151; Walsh F. (2012). Annual Review of Gerontology & Geriatrics 32(1):151–172.
Table 1. Conditions that may lead to the development of frailty while also placing the individuals at various types of
associated risk. An outline of educational and community resources is provided as well.
Boers et al. [15] argue that the existing definitions of frailty are limited because the word
“syndrome“ should be reserved for defining phenotype characteristics that constitute a set of
symptoms and signs representing a health condition. They also argue that the classic World
Health Organization definition of health is outdated and that a new, more dynamic concept of
health as “…the resilience or capacity to cope, and to maintain and restore one’s integrity,
equilibrium, and sense of well-being in three domains: physical, mental, and social…” opens
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the door to simply defining frailty as “the weakening of health” [15–17]. Currently, there is
insufficient evidence to accept a single definition of frailty [14], and the ongoing debate
highlights the need for a consensus [18].
Using the definition of frailty as a “…decreased reserve and resistance to stressors…” [19]
highlights the importance of individualized, careful approach when weighing risks and
benefits of various interventions [20–22]. In this context, an “intervention” could range from
an elective surgical procedure to initial administration of an oral hypoglycemic agent in a
diabetic patient. For example, one prospective study found that patients deemed as “inter-
mediately frail” or “frail” were more likely to experience postoperative complications [23].
Some authors suggest that frailty should be routinely measured as part of the perioperative
patient risk assessment in older individuals, pointing out that most current surgical risk scores
do not adequately take frailty into consideration [24]. In one study, patients deemed fit by
Comprehensive Geriatric Assessment (CGA [25]) with diffuse large-cell lymphoma had better
survival and chemotherapy response rates when compared to their “more frail” counterparts
[26]. One systematic review suggested that more than half of older cancer patients in the United
Kingdom were “pre-frail” or “frail”, and identified that these groups were at increased risk of
all-cause mortality, chemotherapy intolerance, and postoperative complications [27, 28].
Frailty may also compound the problem of pre-existing medical conditions, mainly via
multiple “feedback” mechanisms, where frailty facilitates the downward clinical spiral [29].
For example, recurrent episodes of hypoglycemia may occur unnoticed due to the impaired
autonomic response in the frail, elderly diabetic patient. This, in turn, may result in repeated
subclinical central nervous system insults, which may lead to worsening cognitive dysfunction
(e.g., progressive dementia) and physical frailty [29]. Frailty may also be associated with
greater incidence of cardiovascular death, myocardial infarction, and stroke [30]. Taken
together, the above examples may be applicable across various clinical settings where disease,
treatment, and frailty dynamically interact [31, 32]. Evidence also shows that although patients
considered “pre-frail” and “frail” had greater morbidity and mortality when compared to their
“robust” counterparts, the median age in the three frailty groups was similar, supporting the
notion that both chronological and physiological age play a role in the “frailty equation” [30,
33].
Frailty is also an independent predictor of falls, delirium, disability, and hospitalization [34].
Better understanding of frailty, coupled with the ability to identify it, is critical to our ability
to control, and possibly modulate, associated physiological and cognitive changes. This not
only has significant implications for patients and their quality of life but also presents an
opportunity to reduce health care-associated costs of frailty by focusing on effective preventive
strategies [35–37]. Despite the growing focus around frailty, screening and risk stratification
are still limited, the CGA is underutilized, and the involvement of geriatric specialists is far
from routine [38]. In summary, there is need for better identification of frail patients in order
to optimize their clinical management and adequately counsel patients regarding risks and
benefits of any proposed treatments [39].
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3. Frailty: identification and assessment
The gold standard for identifying frail individuals is the Comprehensive Geriatric Assessment
(CGA) [40]. The CGA requires a team of doctors, nurses, and therapists to jointly establish a
patient’s matrix of bio-psycho-social needs [41, 42]. In studies, CGA has been closely associated
with the Canadian Study of Health and Aging (CSHA) frailty index [43, 44]. Due to the amount
of effort required to complete a CGA for all at-risk patients, it is challenging for the non-
geriatric practitioner to effectively mobilize the required resources. Consequently, extensive
research has been performed to find a simpler method of identifying and quantifying frailty.
Another model outlines a phenotypic definition of frailty [12, 45]. This model, proposed by
Fried, is relatively simple and requires little modification to the routine, standard-of-care
medical practice when collecting and assessing required variables. However, its translation
into clinical practice may be challenging [40]. Critics of Fried’s definition argue that it does not
sufficiently address cognitive aspects of frailty. Some propose that adding a mini mental state
exam (MMSE) and the Isaacs Set test may improve the predictive validity of the combined
screening tests [46]. It has been shown that targeted questionnaires can be very effective in
evaluating frailty in the elderly population, especially when looking at aspects of “psycho-
physical state” and frailty [47]. Such questionnaires may be useful in identifying and quanti-
fying various cognitive and mood aspects of frailty.
One systematic review showed that the most sensitive screening tools used to measure frailty
are gait speed <0.8 m/s, timed-up-and-go-test of >10 s, and the PRISMA 7 score of ≥3 [48]. These
criteria had sensitivities of 0.99, 0.93, and 0.83 and specificities of 0.64, 0.62, and 0.83, respec-
tively [48]. Of importance, most of the research on screening tools originates from the outpa-
tient setting, with relatively less experience regarding screening for frailty in the hospital [49].
In summary, if a CGA is unavailable, the practitioner should utilize multi-modality, phenotype-
based approaches that incorporate multiple, complementary screening tools outlined above.
4. Frailty versus comorbidities: similar but different
The concept of frailty rests on the idea that declining physiological reserve and function leads
to susceptibility toward adverse outcomes and poor resolution of acute medical events and
injuries [40]. At this point, it is important to discuss the relationship between frailty and
comorbidity burden. Although it is intuitive that decline in physiological reserve is related to
age, frailty measurements are independent of chronological age. Chronological age, frailty,
and the increased prevalence of chronic health conditions are inextricably linked. Approxi-
mately 25–50% of the population >85 years of age can be characterized as being frail or
vulnerable to adverse outcomes after an exposure to acute stress [40, 50, 51]. However,
chronological age does not directly correlate with frailty, which is where comorbidity assess-
ment may provide valuable quantitative insight as a co-variate.
There are several comorbidity indices, each of which offers slightly different perspective on
the patient’s comorbidity burden. Although a complete discussion of instruments used to
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quantify comorbidities is beyond the scope of this chapter, we will provide an overview of the
topic. The Charlson Comorbidity Index (CCI) considers a pre-defined, weighted set of medical
diagnoses and has been shown to predict healthcare resource utilization, clinical risk stratifi-
cation, and mortality [52, 53]. The Elixhauser index considers variable characteristics of medical
conditions across different patient populations, using a set of 30 comorbidities to predict
outcomes such as length of stay, hospital charges, and mortality [54]. One Elixhauser index
derivative consists of a simplified score with good utility in estimating the effect of comorbid-
ities on clinical outcomes [55].
The Comorbidity-Polypharmacy Score (CPS) combines comorbidities and polypharmacy into
a simple, yet potentially accurate measurement of frailty [33]. It is a sum of all pre-existing
conditions and medications [56]. CPS weighs the “severity” of comorbidities based on the
number of medications necessary to treat each respective chronic condition [33, 57]. In clinical
studies, CPS correlated with morbidity, mortality, readmissions, post-emergency department
(ED) triage, and the need for discharge to skilled nursing/extended care facility [33, 56–60].
CPS may thus constitute the “missing link” that uses the “intensity” of polypharmacy to
connect the concepts of frailty and comorbidity.
5. Frailty: multidisciplinary and interdisciplinary approaches
Frailty is inextricably associated with several determinants of a patient’s overall health status,
including genetic predispositions, environmental factors, and comorbid conditions [61, 62,
40]. It naturally follows that the optimal approach to caring for frail patients is a collaborative
one [63]. Consequently, treatment teams should include participants from various specialties,
including generalists and specialists, smoking cessation counselors, social workers, mental
health professionals, physical and occupational therapists, nutrition experts, wound care
specialist, and nurses [64–68]. Major themes involved in the overall “frailty equation” are
shown in Figure 2.
A collaborative approach to identification, prevention, and management of frailty can be
facilitated by establishing areas of subspecialty within existing medical disciplines that focus
on the care of the elderly and the frail [69, 70]. For example, during exploratory work on the
concept of geriatric surgery, it was emphasized that this new surgical subspecialty should have
multidisciplinary character [71]. Among other recommendations was the role of the geriatric
service in screening, identifying, and managing the frail patient. Multidisciplinary teams
should consist of surgeons from various subspecialties as well as representatives from medical
specialties (e.g., geriatric medicine, geriatric psychiatry, wound care, palliative care, physical
medicine, and rehabilitation) [71].
Management of frailty includes the coupling of effective prevention with directed therapeutic
approaches [72]. In one study, 188 frail people living at home were randomized to undergo
either physical therapy-based intervention or an educational program (control group) [73].
The study showed improved functional outcomes in the intervention group. In addition,
inactivity and muscle weakness have been found to be significantly associated with frailty [74].
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In another study, there was a strong relationship between daily sedentary time and develop-
ment of physical frailty [75]. This highlights the importance of physical and occupational
therapy as critical components of the multidisciplinary approach to the management and
prevention of frailty. It also supports the inclusion of social interventions to ensure that elderly
patients stay active by participating in various activities or community work.
Figure 2. Major themes and manifestations associated with the development and progression of frailty. Modified with
permission from McDermid et al. [124].
Major components of the frailty syndrome include weight loss [76], sarcopenia [77], and
osteopenia [78, 79]. Consequently, adequate supplementation of protein, calories, and essential
nutrients is important in the treatment and prevention of frailty [77]. At the same time, frailty
can exist in the morbidly obese, corroborating the need for the multidisciplinary team
approach [80]. In the context of osteopenia, it has been demonstrated that a simple intervention,
such as vitamin D supplementation, has been shown to be beneficial in reducing hip fractures
and associated complications in the frail, elderly patient [77, 81–84].
One randomized controlled trial evaluated the effects of nutritional, cognitive, physical, and
combined interventions in frail, older adults. Combined approach utilizing physical exercise,
nutritional supplementation, and cognitive training was effective in reducing frailty [85]. For
some, advanced frailty is synonymous with the commonly used term, “failure to thrive”. The
main purpose of multi-pronged approaches is to prevent or delay the progression of frailty
and to slow down the associated functional decline.
Polypharmacy has been proposed as an indirect reflection of frailty, especially when coupled
with measures of comorbidity [33, 86, 58]. Significant correlations were found between CPS
(Comorbidity-Polypharmacy Score) and a variety of clinical endpoints, including hospital
readmissions, morbidity, mortality, and the need for discharge to skilled nursing facility [57–
60]. Clinical data also suggest that CPS may indeed be a simplified surrogate of “frailty” [33,
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58, 60]. The Beers criteria and STOPP and START criteria are tools to help reduce unnecessary
pharmaceutical use in the frail population and may be helpful in preventing adverse medica-
tion events [87, 88]. In addition, the creation of geriatric units or treatment teams, with staff
specifically trained to treat the frail and elderly, may help ensure that patients are not dis-
charged from hospital on inappropriate medications.
Of importance, frail patients have been found to be more likely to use fall-risk-increasing drugs
(FRIDs) as compared to their less frail counterparts, despite the danger of recurrent falls [89].
This further highlights the need to limit the use of unnecessary medications in the frail patient
population. Although the responsibility for this rests primarily on the prescribing physician,
visiting nurses and pharmacists could play an important role in monitoring for drug-drug
interactions or inappropriate medication use. Given that there is a growing body of evidence
to suggest that patients are more likely to be frail and suffer adverse outcomes if they have
diseases such as cancer [90], renal failure [91], human immunodeficiency virus (HIV) [92], heart
failure [93], or diabetes [94], it seems reasonable that the screening for, and identification of,
frailty in these patient populations may lead to improved outcomes, more appropriate
interventions, and better prevention.
In the emergency department (ED) setting, the challenge of screening for frailty is particularly
difficult, given the time and resource constraints placed on emergency physicians and staff.
One solution is the introduction of specialty teams of practitioners dedicated to assessing
elderly patients arriving to the ED, resulting in the reduction of admissions from nursing
homes [95]. Furthermore, if an elderly patient is evaluated by a geriatric team in the ED, they
are more likely to be assessed using the CGA (Comprehensive Geriatric Assessment), and thus
more readily identified, triaged, and cared for appropriately [96]. Specialty clinics dedicated
to comprehensive and multidisciplinary assessment of frail older persons may be useful not
only in terms of secondary prevention and management of frailty (and hence prevention of
dependency) but also provide an opportunity for more aggressive monitoring and follow-up
of this particular patient population as well as further research [97]. In summary, it is generally
accepted that the identification and management of the frail patient should be overseen by
dedicated specialty teams. Such teams should ideally consist of appropriately trained physi-
cians, advanced practitioners, geriatric nurse specialists, physical therapists, pharmacists, and
nutrition experts, and other health professionals.
6. Frailty: interventions and pitfalls
As we age, our bodies exhibit changes at both molecular and cellular levels. Some molecular
changes are shared between tissue types and organ systems, whereas others are unique and
specific. With advancing age, body composition changes, as evidenced by loss of muscle mass
and increased percentage of body fat [98]. There is also a loss of bone mass, narrowing of joint
spaces, and a decrease in total body water [98, 99]. Muscle mass may decrease by as much as
50% and body fat may increase to comprise up to 30% of body weight [99]. Once a “frail or
pre-frail” individual is identified, it is critical to promptly begin interventions to slow down
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the progression of frailty. As outlined previously, these interventions should involve a well-
coordinated, multidisciplinary approach. Key components of such a coordinated approach—
physical activity, nutritional support, psycho-social support, and pharmaceutical management
—are discussed.
Encouraging patients to remain active is among the most successful interventions to address
frailty, both from the physical and cognitive perspective [100–102]. In a randomized study, 6
months of physical therapy reduced the functional decline of elderly patients living at home
[74]. A meta-analysis investigating the impact of exercise on the quality of life in frail patients
showed that exercise improves gait, balance, and performance of activities of daily living
(ADLs) [103]. Of note, the majority of available research in this area involves supervised, short-
term exercise regimens, making it difficult to generalize results to other settings. Furthermore,
not all interventions were equally effective, with only three out of eight specific interventions
reporting positive results in one analysis [104]. Finally, it is important for clinicians to deter-
mine if the patient is physically ready to begin exercise routines before proceeding, with
emphasis being placed on ensuring safe environment for physical activity [105].
The importance of key factors behind nutritional supplementation (e.g., caloric, protein, and
essential nutrient intake) has been studied extensively in relation to frailty. One study found
that decreased caloric intake (e.g., <21 kcal/kg), low protein, and vitamin D and vitamin E
intake were all associated with frailty [106]. While research on nutritional supplementation is
still limited in the frail population, it is known that protein supplementation in elderly can be
beneficial [107]. At the same time, a multicenter trial found that vitamin D supplementation
did not improve rehabilitation outcome in frail individuals following injury [108]. There is
some evidence that regular consumption of polyunsaturated fatty acids (PUFA) may be of
benefit in modifying cognitive decline associated with aging [109]. The clinician should
remember that isolated dietary interventions are not sufficient to combat frailty. With much
more research needed in this area, there is thus far no definitive demonstration of benefit of
nutritional interventions on measures of disability [104].
Pharmaceutical interventions in the frail population have revolved around the use of targeted
therapies, coupled with polypharmacy reduction [107, 110, 111]. Of note, targeted programs
to reduce polypharmacy result in fewer adverse events and better clinical outcomes [112–
114]. In terms of specific interventions, anabolic agents have been shown to increase muscle
mass but failed to improve strength or function in elderly patients [107]. Important research
in the area of frailty involves erythropoietin and its potential neuroprotective and regenerative
properties [100], angiotensin-converting enzyme (ACE) inhibitors [115], hormone therapies
[116], and other pharmaceutical interventions to reverse sarcopenia [117] and cognitive
decline [118, 119].
Given the above information in aggregate, it is reasonable to state that multi-pronged,
coordinated programs encompassing physical activity, social support, nutritional supplemen-
tation, and pharmacologic interventions will be more effective than isolated efforts in each of
the above areas [100–102, 107, 110, 111, 120].
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7. Frailty: focus on prevention and care optimization
In the context of prevention and care optimization, it is critical to define and quantify the types
of adverse events that are more prevalent within the “frail” and “pre-frail” populations. For
example, frailty is associated with various adverse occurrences such as falls, disability, and
death [121, 122]. Frail patients are more susceptible to skeletal fractures, healthcare associated
infections, delirium, incontinence, malnutrition, dehydration, and skin breakdown [121, 123].
These factors all directly and indirectly contribute to morbidity, disability, and mortality. Injury
and acute illness have a disproportionate impact on frail patients because of the impaired
healing process, slower physical recovery, and longer hospital and intensive care stays when
compared to non-frail patients [124, 125]. Frail patients also have higher rates of functional
dependence, hospital readmission, and are less likely to go back to independent living after
discharge [57, 126]. Because this negative feedback cycle is often difficult to halt once it has
begun, it is critical that early prevention is implemented. Promoting healthy and positive
behaviors (e.g., physical activity, reducing tobacco/alcohol use), and ensuring adequate
community support helps reduce the risk of adverse events [127, 128]. Because acute exacer-
bations of chronic illness such as diabetes, heart failure, and pulmonary disease can quickly
trigger complications in frail patients, regular provision of preventive care and structured
medical follow-up are vitally important [129].
As outlined in previous sections of this chapter, adequate nutrition is important to both
prevention and recovery from various health crises. Physiological changes due to aging and
comorbid illness predispose the older population to malnutrition [130, 131]. With this in mind,
both identification and prevention of nutritional deficiencies become critical in the multi-
pronged approach to the frail patient [132, 133]. Finally, whereas in the past there existed a
clear separation between acute care (i.e., inpatient hospitals, outpatient clinics) and long-term
care (i.e., retirement homes, assisted living, home health), skilled nursing facilities have
gradually begun to provide subacute care and rehabilitation services [134, 135]. Assisted living
has played a major role in caring for frail patients, with many assisted living facilities offering
services such as medication management, skilled nursing care, and extensive functional
support [136]. Also important is the rapidly evolving concept of “chronic critical illness”
associated with prolonged recovery from serious illness in the setting of pre-existing or newly
acquired frailty [137]. A new “level of care” in the health care continuum arose as a response
to “chronic critical illness” in the form of Long-Term Acute Care units [137].
The Older Americans Act (OAA) defines a multipurpose senior center as “…a community
facility for the organization and provision of a broad spectrum of services, which shall include
provision of health (including mental health), social, nutritional, and educational services and
the provision of facilities for recreational activities for older individuals” [138]. In 2011, the
National Council on Aging (NCoA) issued a reauthorization of the Older Americans Act which
focused on multipurpose senior centers for positive aging, proposing that existing senior
centers modernize to foster innovation, leadership, and capacity-building [139]. Many facilities
were recognized as centers for positive aging even before the reauthorization. These centers
feature specialty teams consisting of geriatricians, nurse practitioners, and social workers who
provide consultations, comprehensive evaluations, and recommendations for senior care.
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These teams work with patients, family members, and primary care providers to evaluate the
patient's physical, emotional, social, and functional needs and assist in planning for the future
[140].
Aging is associated with physical, psychological, and social factors that collectively contribute
to the development of dependence. Consequently, frail patients should be encouraged to take
active part in their own medical care. Active patient participation allows medical staff,
caretakers, and family members to better understand expectations, goals of care, and treatment
outcomes. The introduction of electronic health records allows patients to become engaged in
their own care [141]. It is hoped that patient participation in self-management programs can
translate into better outcomes, especially for the frail and elderly patients [142].
8. Rehabilitation: managing the frail patient
Injury and acute illness among older adults, frail or not, is always a significant event. Because
functional capacity is likely to further decline following injury or acute illness, rehabilitation
is of utmost importance in this setting, especially for older, frail patients [143]. To maximize
rehabilitation potential, a multidisciplinary approach involving coordinated medical and
nursing care appears to be the most effective way of optimizing the patient’s functional status
[144].
Because severe cognitive impairment is associated with poor functional recovery, individuals
who fall into this category require special attention [145, 146]. Cognitive tests to determine
baseline status and to predict potential for improvement may be helpful [147]. Of note,
individuals with below average functional status at baseline have the most to gain from
rehabilitation. In a society in which length and type of medical care are determined with cost
in mind, caution must be taken to prevent short-term cost-saving measures from compromis-
ing long-term outcomes in frail patients undergoing rehabilitation [144, 148].
In order to create an environment where frail patients can thrive, it is important to focus on
preventing adverse events (and other factors) that may negatively affect the recovery and
rehabilitation process. Depression and cognitive impairment correlate with negative outcomes
in elderly patients undergoing rehabilitation [149, 150]. In addition, pressure ulcers, urinary
incontinence, and hearing impairment, when present, may further worsen the overall func-
tional decline [151]. Many of these factors can be prevented, treated, or otherwise modified by
leveraging various ancillary services to improve outcomes [152]. Patients who are unable to
control their bowel and bladder function greatly benefit from interventions (i.e., rotation,
pressure pads, etc.) that prevent pressure ulcers [153].
9. Miscellaneous topics: futility, delirium, and cognitive decline
The challenges with futility often have as much to do with the care provider as with the patient
[154]. It is generally difficult to achieve agreement among providers caring for an individual
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and between different specialties consulting on the same patient. Further complicating these
situations is the transition from “generally well” to “functional ill” to “not well/frail” to
“acutely sick/dying” [155]. As physicians, we may be able to “see” the differences, but the
family may simply see their very sick loved one still connected to “all of those machines/drips/
monitors”, yet not necessarily grasping the true severity of illness [156]. It is often difficult to
achieve adequate understanding of futility after the intensive care team has been employing
aggressive management approaches for days, weeks, or even months [157, 158].
Additional level of complexity emerges due to the lack of universal, legal definition of futility
and state-to-state variations regarding existing options and responsibilities [159]. For example,
Texas has a well-defined (but still controversial) futility statute [160, 161], while other localities
have no formal statutes recognizing (or defining) futility [162]. Most biomedical ethicists
support the autonomy of an individual physician to refuse a treatment or procedure that he
or she is morally, ethically, or religiously opposed to (or feels that it would cause undue harm
to the patient). In exchange, that physician has an obligation to refer the patient to another
provider [163]. Abandonment, without transferring care to another competent individual, is
never an option [164]. When approaching a futile situation, key questions need to be answered
in order to better guide the course of goals-of-care discussions and subsequent magnitude of
therapeutic interventions: (a) What are the values of the patient/family? (b) What gives
meaning to a life of the patient and his/her family? (c) What qualities/aspects of care would
represent unacceptable burdens? (d) What are the patient’s hopes and fears?
Important considerations for individual providers include (a) clarity over what is determined
to be futile; (b) the ability to recognize own biases, especially in the context of a futile situation;
(c) maintenance of consistent communication within the team and with the patient/family; (d)
having an accurate assessment of patient understanding and competence/capacity; (e)
providing consistent palliation/palliative care (understanding physical, emotional, social, and
spiritual aspects); and (f) consideration of all available options including hospice care when
meeting with the patient and his/her family. A summary of the above considerations is
provided in Table 2.
One should initiate the discussion about futility by providing an honest and realistic assess-
ment of the medical situation [165]. A parallel assessment of the patient/family’s values and
goals of care is also made during the process. The ability to establish a collaborative working
relationship between the health care team and the patient/family will help facilitate subsequent
understanding in case that any future aggressive care becomes futile, and a strictly palliative
approach (e.g., hospice) is more in keeping with patient/family goals [166, 167]. Of importance,
key ethical principles of autonomy, beneficence, non-maleficence, and justice must be embed-
ded throughout the entire process [168–170]. Together, these principles can help guide the
creation of a rational plan of care [168–170]. Considering the unit of care as the “patient-family”
as opposed to just the patient may also broaden our understanding of unique dynamics that
may influence the decision-making process. Defining futility, especially in the geriatric
population, must include a broad-based assessment consisting of the following key elements
[154, 171–173]:
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Communication considerations
 Ask-Tell-Ask: Do not make any assumptions. Answer honestly and directly.
 Sit-Listen-Make eye contact: Make sure that everyone is there who needs to be there.
 SPIKES: Set up, Perception, Invitation, Knowledge, Emotions, Strategy/Summary.
 Address emotion: Name; Understand; Respect; Support; Explore
Advance care planning: Start early; Review with any change in status/level of care; Know applicable status levels;
Conversations now a billable visit under Medicare regulations.
 Living will versus advance directive
 Durable power of attorney for health
 Guardianship—If no other acceptable options exist, consider sooner than later if patient lacks capacity or
competence and no other documents have been completed.
 POLST—Physician Orders for Life-Sustaining Treatment should be completed for anyone with frailty or anyone in
whom you would not be surprised if they were to die within the next year.
Risk of abuse and social vulnerability
 Frailty increases the risk of abuse
 Prevention and education
 Working closely with patients and families
 Available programs and organizations
Compiled from Eng et al. (1997) J Am Geriatr Soc 45(2):223–232 ; Evans et al. (2006) The Cancer Journal12(5): 417–424; Harris
(2007) Postgraduate Obstetrics & Gynecology27(4): 1–4; Wittenberg-Lyles et al. (2008) Social Science & Medicine 66(11): 2356–
2365.
Table 2. Important considerations and concepts when communicating about frailty and related issues, including end-
of-life issues.
• Patient factors: (a) comorbid medical conditions; (b) functional capacity (e.g., Karnofsky/
Palliative Performance Scale or PPS [174]); (c) medication profile; (d) competence/mental
capacity [175]; (d) quality of life; (e) overall goals and values; (f) documented wishes
(advance directive/living will/Physician Orders for Life-Sustaining Treatment (POLST)
[176])
• Social and cultural factors: (a) Where does the patient live? (b) Who does the patient live with?
(c) Who helps them, including decisional support? (d) What are their financial resources or
limitations? (e) What is the patient’s access to care? Available transportation? (f) What is the
patient’s cultural/ethnic background? (g) Regarding community resources, who is in the
“extended family”? (h) Is the patient safe? Is there any potential for abuse?
• Emotional factors: (a) Is there an underlying metal illness? (b) Is there an underlying substance
abuse/addiction? (c) Is there a suspicion of elder abuse or neglect? (d) Is loneliness/isolation
an issue?
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• Spiritual/religious factors [177]: (a) Is faith important to the patient/family? (b) How does faith
or belief impact decision-making? (c) Does the patient have a faith community?
Communication about futility should begin well before the “futility line” is crossed. It is
important to consider the whole person when discussing subjects such as living wills and
advance directives, and the conversation should be as much about the value, meaning, and
quality of life as it is about whether to resuscitate someone [178]. Framing a conversation
around realistic hopes and goals enables the patient and his/her family to clearly identify
appropriate goals of care and, when appropriate, initiate discussions about palliative care,
hospice, and Physician Orders for Life-Sustaining Treatment (POLST [179]) with a goal of
avoiding unwanted medical situations (e.g., hospitalization, intensive care stays, long-term
dependence on nursing care, etc.) [180, 181]. Discussing how to live, for a frail elderly indi-
vidual with multiple medical conditions, should also include conversations about how to die
[182]. Asking people who they are and what is most important to them allows the practitioner
to frame recommendations for care in terms of the patient’s goals, and not in terms of aggressive
treatments that may be more burdensome than beneficial. Also, framing the conversation
around positives helps preserve dignity in end-of-life care (e.g., “hospice care can allow you
to be at home with your family and be comfortable” versus “there is nothing more we can do
for you so we are calling hospice”) [183].
Aging is a loss of homeostasis, or a breakdown in maintenance of specific molecular structures
and pathways. It is the inevitable consequence of evolved anatomy and physiology of an
organism [184]. Determining what constitutes normal aging and whether a decline in func-
tional ability is attributable to disease or pathology can be challenging. While a series of
changes occur with “normal” aging, a major characteristic of aging is the heterogeneity among
the rates of functional decline [99].Time, genetics, disease, environmental, and behavioral
factors all contribute to aging and frailty [185–188].The human body maintains significant
reserve capacity, allowing individuals to endure and overcome a great deal of stress. Aging
lowers the ceiling for an organ’s or individual’s reserve, and older adults have a lowered
maximal capability when compared to younger individuals [99]. Thus, biologic age (repre-
sented by frailty), based on an individual’s functional capacity, and not chronologic age, is the
more optimal metric for studying the phenomenon of aging. Functional capacity is a direct
measure of the ability of cells, tissues, and organ systems to function properly and optimally,
and is influenced by both genes and environment[185–188]. Gradual changes in cells, tissues,
and organs of the body lead to the eventual breakdown of maintenance processes—an
inevitable consequence of the evolved anatomy and physiology of the organism [184].
10. Conclusions
As the geriatric segment of the world population continues to grow, the topic of frailty is bound
to gain prominence around the globe. Despite significant amount of research available in this
area, better understanding of frailty and its underlying mechanisms is required. The concept
of frailty has evolved significantly since the mid-twentieth century, from the stereotypical
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description of a “thin, stooped, slow octogenarian” [7] to more contemporary definitions
grounded in scientific evidence and practice. In this chapter, we reviewed some of the key
issues that practitioners may encounter when treating frail patients, including identification
of frailty, preventive and therapeutic options, common pitfalls, and related topics, including
an overview of “goals of care”/end-of-life considerations.
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